Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Receives 510(k) Clearance for AdV/hMPV/RV Assay on Panther Fusion System

NEW YORK (GenomeWeb) – Hologic said today that the US Food and Drug Administration has granted 510(k) clearance for its Panther Fusion AdV/hMPV/RV assay, a multiplexed test that runs on the firm's Panther Fusion system. 

The new test, the third respiratory assay available on the Panther Fusion system, detects adenovirus, human metapneumovirus, and rhinovirus, and it complements the Panther Fusion Flu A/B/RSV assay and the Panther Fusion Paraflu assay, both of which received clearance in October.

Tom West, president of the diagnostic solutions division at Hologic, said that the clearance and launch of the new assay completes the firm's initial set of modular assays for respiratory viruses.

Hologic said that some respiratory panels on the market require testing for 20 or more targets even when a physician has only requested three or four, which makes testing time-consuming and expensive for laboratories. The Panther Fusion assays offer a modular approach to syndromic respiratory testing via the ability to run one, two, or all three assays from a single patient specimen, the firm said.

The firm noted that Panther Fusion is available as a full system, or a Panther Fusion module that can be attached to existing Panther systems in the field to extend testing capabilities. The Panther Fusion module adds the capacity to run PCR assays in addition to tests based on transcription-mediated amplification, the proprietary chemistry behind Hologic's Aptima brand. 

Adenoviruses cause respiratory illnesses ranging from the common cold to pneumonia, croup, and bronchitis, and they can cause illnesses such as gastroenteritis, conjunctivitis, cystitis, and neurological disease. hMPV is a common respiratory pathogen, mostly experienced by infants and young children. The virus is associated with both upper and lower respiratory tract infections and may be a trigger for asthma. Rhinoviruses are the causative pathogens in more than half of viral respiratory infections, and they are associated with acute exacerbations of respiratory conditions, including asthma, sinusitis, otitis media, and chronic obstructive airway disease, Hologic said.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.